Literature DB >> 18498951

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Andrew E Epstein, John P DiMarco, Kenneth A Ellenbogen, N A Mark Estes, Roger A Freedman, Leonard S Gettes, A Marc Gillinov, Gabriel Gregoratos, Stephen C Hammill, David L Hayes, Mark A Hlatky, L Kristin Newby, Richard L Page, Mark H Schoenfeld, Michael J Silka, Lynne Warner Stevenson, Michael O Sweeney, Sidney C Smith, Alice K Jacobs, Cynthia D Adams, Jeffrey L Anderson, Christopher E Buller, Mark A Creager, Steven M Ettinger, David P Faxon, Jonathan L Halperin, Loren F Hiratzka, Sharon A Hunt, Harlan M Krumholz, Frederick G Kushner, Bruce W Lytle, Rick A Nishimura, Joseph P Ornato, Richard L Page, Barbara Riegel, Lynn G Tarkington, Clyde W Yancy.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18498951     DOI： 10.1016/j.jacc.2008.02.032

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  355 in total

Review 1.  [Implantation of cardioverter-defibrillators. How much anesthesia is necessary?].

Authors:  T Sellmann; M Winterhalter; U Herold; P Kienbaum
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

Review 2.  Dual- versus single-coil implantable defibrillator leads: review of the literature.

Authors:  Jörg Neuzner; Jörg Carlsson
Journal:  Clin Res Cardiol       Date:  2012-01-10       Impact factor: 5.460

3.  Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Authors:  Gustavo Lopera; Gerald A Beathard; Jose Exaire; Roger Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2012-06       Impact factor: 1.900

Review 4.  Multimodality imaging in interventional cardiology.

Authors:  Bas L van der Hoeven; Martin J Schalij; Victoria Delgado
Journal:  Nat Rev Cardiol       Date:  2012-02-14       Impact factor: 32.419

Review 5.  Isolated non-compaction cardiomyopathy.

Authors:  Rolf Engberding; Claudia Stöllberger; Peter Ong; Talat M Yelbuz; Birgit J Gerecke; Günter Breithardt
Journal:  Dtsch Arztebl Int       Date:  2010-03-26       Impact factor: 5.594

6.  Single photon emission computed tomography (SPECT) techniques for resynchronization: phase analysis and equilibrium radionuclide angiocardiography.

Authors:  Kenneth C Bilchick
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

7.  End-stage renal disease: sudden cardiac death: stratifying risk in dialysis patients.

Authors:  Rod Passman; Charles A Herzog
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

8.  Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial.

Authors:  Gery Tomassoni; James Baker; Raffaele Corbisiero; Charles Love; David Martin; Robert Sheppard; Seth J Worley; Kwangdeok Lee; Imran Niazi
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-18       Impact factor: 1.468

9.  Prolongation of PR interval is associated with endothelial dysfunction and activation of vascular repair in high-risk cardiovascular patients.

Authors:  Yap-Hang Chan; Chung-Wah Siu; Kai-Hang Yiu; Yuen-Fung Yiu; Kui-Kai Lau; Tai-Hing Lam; Chu-Pak Lau; Hung-Fat Tse
Journal:  J Interv Card Electrophysiol       Date:  2013-02-07       Impact factor: 1.900

10.  Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus.

Authors:  Brian S Moyers; Eric A Secemsky; Eric Vittinghoff; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue; Zian H Tseng
Journal:  Am J Cardiol       Date:  2014-01-16       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.